Physician profile
James W Cox
NPI 1932100542
$20,893.73
in general payments reported to CMS, 2019-2025
40 companies · $7,875 in 2025
The $7,875 reported for 2025 was more than what 75% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,340 · 2020: $373 · 2021: $486 · 2022: $2,888 · 2023: $2,621 · 2024: $5,310 · 2025: $7,875.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,000 · Food and Beverage: $4,419 · Travel and Lodging: $2,347 · Education: $39.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,000.00 |
| Food and Beverage | $4,419.35 |
| Travel and Lodging | $2,347.01 |
| Education | $39.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $7,177.50 | 2019-2025 | Carto 3, Soundstar |
| Medical Device Business Services, INC. | $4,875.00 | 2022-2024 | Carto 3 |
| Atricure, INC. | $2,909.46 | 2021-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System, Synergy Ablation System |
| Boston Scientific Corporation | $1,366.26 | 2019-2025 | Watchman Flx, Watchman Access System, Rhythmia Mapping System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $945.67 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $351.22 | 2019-2023 | Xarelto |
| Amgen INC. | $327.27 | 2019-2025 | Repatha, Repatha |
| Edwards Lifesciences Corporation | $312.62 | 2019-2025 | |
| Abbott Laboratories | $294.91 | 2019-2025 | Ensite, Viewmate |
| Novartis Pharmaceuticals Corporation | $289.25 | 2019-2020 | |
| Pfizer INC. | $225.73 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $154.15 | 2019-2025 | Camzyos, Eliquis |
| Kiniksa Pharmaceuticals International, Plc | $150.70 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $148.88 | 2023 | Arcalyst |
| Cardiva Medical, INC. | $145.32 | 2023-2025 | Cardiva Vascade 6/7f Vcs, Ensoetm, Savvywire |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $118.55 | 2024 | Barostim Neo System |
| Inspire Medical Systems, INC. | $115.36 | 2024-2025 | Inspire |
| Sanofi-Aventis U.S. LLC | $103.54 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $99.23 | 2019-2024 | Wainua, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.39 | 2019-2023 | Jardiance |
| Cardiovascular Systems INC. | $77.27 | 2019 | |
| Medtronic, INC. | $71.34 | 2021-2023 | Linq II |
| Heartflow, INC. | $67.75 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $59.16 | 2024-2025 | Uptravi, Opsumit |
| Abiomed | $55.91 | 2023 | Impella |
| Daiichi Sankyo INC. | $52.84 | 2023 | Injectafer |
| Gilead Sciences, INC. | $36.69 | 2019 | |
| Elutia, INC. | $31.15 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $28.64 | 2023 | Evkeeza |
| Convatec INC. | $25.24 | 2024 | |
| Novo Nordisk INC | $24.28 | 2023 | Ozempic, Rybelsus |
| Alnylam Pharmaceuticals INC. | $23.91 | 2019 | |
| Philips North America LLC | $22.70 | 2019 | |
| Vifor Pharma, INC. | $21.06 | 2019 | |
| Vital Connect, INC | $20.00 | 2024 | Vitalpatch Rtm |
| Catheter Precision INC. | $19.88 | 2024 | |
| Scpharmaceuticals INC. | $19.51 | 2025 | |
| Irhythm Technologies, INC. | $12.90 | 2022 | |
| Lundbeck LLC | $12.10 | 2019 | |
| Ge Healthcare | $11.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.